PROC
Summary: This gene encodes a vitamin K-dependent plasma glycoprotein. The encoded protein is cleaved to its activated form by the thrombin-thrombomodulin complex. This activated form contains a serine protease domain and functions in degradation of the activated forms of coagulation factors V and VIII. Mutations in this gene have been associated with thrombophilia due to protein C deficiency, neonatal purpura fulminans, and recurrent venous thrombosis.[provided by RefSeq, Dec 2009].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| protein C, inactivator of coagulation factors Va and VIIIa | MIM:612283 | Ensembl:ENSG00000115718 | HGNC:HGNC:9451 | PA33799 | 2q14.3 |
GO terms in PROC
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IBA | GO:0004252 | serine-type endopeptidase activity |
| MF | IMP | GO:0004252 | serine-type endopeptidase activity |
| MF | TAS | GO:0004252 | serine-type endopeptidase activity |
| MF | IEA | GO:0005509 | calcium ion binding |
| MF | IPI | GO:0005515 | protein binding |
| BP | IEA | GO:0001889 | liver development |
| BP | NAS | GO:0006508 | proteolysis |
| BP | TAS | GO:0006888 | ER to Golgi vesicle-mediated transport |
| BP | TAS | GO:0007596 | blood coagulation |
| BP | IBA | GO:0030195 | negative regulation of blood coagulation |
| BP | TAS | GO:0030195 | negative regulation of blood coagulation |
| BP | IMP | GO:0043066 | negative regulation of apoptotic process |
| BP | TAS | GO:0043687 | post-translational protein modification |
| BP | TAS | GO:0044267 | cellular protein metabolic process |
| BP | IEA | GO:0044537 | regulation of circulating fibrinogen levels |
| BP | IMP | GO:0050728 | negative regulation of inflammatory response |
| BP | IMP | GO:0050819 | negative regulation of coagulation |
| BP | IMP | GO:1903142 | positive regulation of establishment of endothelial barrier |
| CC | NAS | GO:0005576 | extracellular region |
| CC | TAS | GO:0005576 | extracellular region |
| CC | IBA | GO:0005615 | extracellular space |
| CC | IDA | GO:0005783 | endoplasmic reticulum |
| CC | TAS | GO:0005788 | endoplasmic reticulum lumen |
| CC | IDA | GO:0005794 | Golgi apparatus |
| CC | TAS | GO:0005796 | Golgi lumen |
Gene expression in normal tissue: PROC
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in PROC
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| pid | integrin2_pathway | Beta2 integrin cell surface interactions |
| pharmgkb | PA145011114 | Warfarin Pathway, Pharmacodynamics |
| kegg | hsa04610 | Complement and coagulation cascades - Homo sapiens (human) |
| wikipathways | WP3896 | Dengue-2 Interactions with Complement and Coagulation Cascades |
| wikipathways | WP558 | Complement and Coagulation Cascades |
| reactome | R-HSA-109582 | Hemostasis |
| reactome | R-HSA-140837 | Intrinsic Pathway of Fibrin Clot Formation |
| reactome | R-HSA-140875 | Common Pathway of Fibrin Clot Formation |
| reactome | R-HSA-140877 | Formation of Fibrin Clot (Clotting Cascade) |
| reactome | R-HSA-159740 | Gamma-carboxylation of protein precursors |
| reactome | R-HSA-159763 | Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus |
| reactome | R-HSA-159782 | Removal of aminoterminal propeptides from gamma-carboxylated proteins |
| reactome | R-HSA-159854 | Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| reactome | R-HSA-163841 | Gamma carboxylation, hypusine formation and arylsulfatase activation |
| reactome | R-HSA-202733 | Cell surface interactions at the vascular wall |
| reactome | R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| reactome | R-HSA-392499 | Metabolism of proteins |
| reactome | R-HSA-597592 | Post-translational protein modification |
| reactome | R-HSA-8957275 | Post-translational protein phosphorylation |
| biocarta | extrinsicpathway | extrinsic prothrombin activation pathway |
| biocarta | gsk3pathway | inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages |
| biocarta | hespathway | segmentation clock |
| biocarta | intrinsicpathway | intrinsic prothrombin activation pathway |
| biocarta | pitx2pathway | multi-step regulation of transcription by pitx2 |
| biocarta | tgfbpathway | tgf beta signaling pathway |
| biocarta | wntpathway | wnt signaling pathway |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD347 | Y-39983 | 1 |
| iGMDRD512 | nutlin 3 | 1 |
| iGMDRD307 | Manumycin A | 3 |
| iGMDRD262 | KU-55933 | 1 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD382 | CEP-701 | 1 |
| iGMDRD497 | 16beta-Bromoandrosterone | 3 |
| iGMDRD652 | UNC0638 | 3 |
| iGMDRD345 | Compound 10b [PMID: 11504634] | 1 |
| iGMDRD160 | Cis-Platin | 1 |
| iGMDRD456 | Crizotinib | 1 |
| iGMDRD536 | PLX-4720 | 2 |
| iGMDRD753 | G007-LK | 1 |
| iGMDRD351 | GW843682X | 4 |
| iGMDRD85 | Ursolic acid | 1 |
| iGMDRD132 | (-)-gallocatechin-3-O-gallate | 2 |
| iGMDRD177 | Teniposide | 2 |
| iGMDRD1014 | Tankyrase inhibitor | 4 |
| iGMDRD901 | ELCPK | 2 |
| iGMDRD227 | Fatostatin A | 1 |
| iGMDRD271 | Brefeldin A | 3 |
| iGMDRD68 | Paclitaxel | 1 |
| iGMDRD459 | RO-3306 | 1 |
| iGMDRD481 | Dactolisib | 1 |
| iGMDRD565 | BI-D1870 | 1 |
| iGMDRD882 | CIL41 | 3 |
| iGMDRD414 | MST-312 | 2 |
| iGMDRD42 | Vorinostat | 2 |
| iGMDRD353 | PD0325901 | 1 |
| iGMDRD82 | Quiflapon | 1 |
| iGMDRD246 | NPC26 | 6 |
| iGMDRD300 | Tozasertib | 5 |
| iGMDRD387 | CHIR-99021 | 1 |
| iGMDRD136 | Nutlin-3 | 1 |
| iGMDRD494 | Neopeltolide | 2 |
| iGMDRD63 | Camptothecin | 1 |
| iGMDRD163 | all trans Retinoic Acid | 1 |
| iGMDRD201 | SKI II | 2 |
| iGMDRD253 | Vincaleukoblastine | 1 |
| iGMDRD230 | JW 55 | 1 |
| iGMDRD608 | Refametinib | 1 |
| iGMDRD519 | GDC-0941 | 1 |
| iGMDRD378 | ZM-447439 | 1 |
| iGMDRD401 | Afatinib | 1 |
| iGMDRD297 | Austocystin D | 5 |
| iGMDRD134 | Sorafenib | 1 |
| iGMDRD255 | SB225002 | 5 |
| iGMDRD613 | CHEMBL258148 | 2 |
| iGMDRD491 | TAE-684 | 1 |
| iGMDRD509 | NVP-BHG712 | 1 |
| iGMDRD870 | BRD63610 | 5 |
| iGMDRD574 | Ruxolitinib | 1 |
| iGMDRD309 | 17AAG | 1 |
| iGMDRD782 | DC-45-A2 | 2 |
| iGMDRD398 | Sepantronium | 5 |
| iGMDRD562 | Navitoclax | 8 |
| iGMDRD185 | DMOG | 1 |
| iGMDRD312 | Pelitinib | 1 |
| iGMDRD131 | Erlotinib | 1 |
| iGMDRD48 | Dexamethasone | 2 |
| iGMDRD79 | Gemcitabine | 3 |
| iGMDRD522 | ML-030 | 3 |
| iGMDRD594 | AZD-8055 | 1 |
| iGMDRD237 | ABT-751 | 3 |
| iGMDRD352 | PD-0325901 | 1 |
| iGMDRD341 | Triacsin c | 4 |
| iGMDRD154 | NSC23766 | 3 |
| iGMDRD511 | CHEMBL399379 | 2 |
| iGMDRD605 | AZD6482 | 2 |
| iGMDRD251 | ML162 | 2 |
| iGMDRD121 | GMX1778 | 1 |
| iGMDRD202 | Curcumin | 2 |
| iGMDRD158 | NSC141540 | 3 |
| iGMDRD77 | Itraconazole | 4 |
| iGMDRD105 | Triptolide | 3 |
| iGMDRD329 | Merck60 | 2 |
| iGMDRD119 | Temsirolimus | 1 |
| iGMDRD871 | BRD6368 | 2 |
| iGMDRD286 | Nsc 632839 | 3 |
| iGMDRD322 | FK 866 | 1 |
| iGMDRD654 | SL 0101-1 | 1 |
| iGMDRD420 | Leucascandrolide A | 3 |
| iGMDRD409 | Saracatinib | 1 |
| iGMDRD151 | CHM-1 | 2 |
| iGMDRD76 | Simvastatin | 3 |
| iGMDRD126 | Tipifarnib | 2 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD779 | PRL-3 Inhibitor I | 2 |
| iGMDRD546 | BMS-754807 | 3 |
| iGMDRD670 | ML 210 | 2 |
| iGMDRD427 | ABT737 | 1 |
| iGMDRD61 | Kinetin riboside | 1 |
| iGMDRD748 | PHA-665752 | 1 |
| iGMDRD639 | YK 4-279 | 1 |
| iGMDRD394 | BX-795 | 1 |
| iGMDRD679 | Bistramide A | 2 |
| iGMDRD474 | Avrainvillamide | 3 |
| iGMDRD226 | ML006 | 3 |
| iGMDRD284 | Palbociclib | 2 |
| iGMDRD117 | Docetaxel | 1 |
| iGMDRD207 | Capsaicin | 3 |
| iGMDRD146 | Elesclomol | 1 |
| iGMDRD780 | PP-30 | 2 |
| iGMDRD888 | Compound 44 | 3 |
| iGMDRD730 | Kahalalide F | 4 |
| iGMDRD399 | Selumetinib | 6 |
| iGMDRD133 | Lapatinib | 2 |
| iGMDRD874 | BRD8958 | 2 |
| iGMDRD64 | Parbendazole | 2 |
| iGMDRD190 | Nilotinib | 1 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in PROC

